ClinicalTrials.gov
ClinicalTrials.gov Menu

Organizational Infrastructure Pediatric Plan in Bronchiolitis Epidemics (OIPP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03663660
Recruitment Status : Completed
First Posted : September 10, 2018
Last Update Posted : September 10, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier

Brief Summary:

Acute bronchiolitis is a frequent respiratory viral infection of infants, responsible for 460,000 new cases per year in France. Over the years, the number of hospitalizations during the epidemic season appears to be increasing. Bronchiolitis epidemics lead to recurrent hospital disruption. The current trend towards a reduction of hospital beds is exacerbating the pressure on bronchiolitis epidemics on healthcare systems.

In this context, the pediatric departments of Montpellier University Hospital, France, designed in 2014 a common organizational infrastructure pediatric plan (OIPP) to to adapt to these multiple constraints while respecting the quality of care.

This plan includes a referral flowchart for hospitalized children, an increase in medical and paramedical staff and a restructuring of the pediatric units, with a specific stratification into 4 levels of care.

The study aims to assess the impact of our OIPP on the overall length of stay for children hospitalized for bronchiolitis. The investigator also intend to measure the impact of the OIPP on the length of stay within each unit, the number of transfers from one unit to the other and the number of readmissions within 30 days after hospital discharge. The cost of the implementation of the OIPP in the structure will be analyzed.


Condition or disease Intervention/treatment
Bronchiolitis Other: Organizational infrastructure pediatric plan (OIPP)

Detailed Description:
The investigator compared data between two periods of time, e.g. the two consecutive years before the beginning of the OIPP (winters 2012-2013 and 2013-2014) and two first years after the beginning of the OIPP (winters 2015-2016 and 2016-2017).

Study Type : Observational
Actual Enrollment : 1636 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Design of an Organizational Infrastructure Pediatric Plan to Deal With Bronchiolitis Epidemics: Impact on Length of Stay and Quality of Care in a Tertiary Care Regional Hospital
Actual Study Start Date : April 1, 2018
Actual Primary Completion Date : May 1, 2018
Actual Study Completion Date : June 19, 2018

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
before the OIPP
Period 1 : Children hospitalized before the OIPP implementation
after the OIPP implementation
Period 2 :Children hospitalized after the OIPP implementation
Other: Organizational infrastructure pediatric plan (OIPP)
Restructuration of the hospital sectors with a stratification of health care into 4 levels.




Primary Outcome Measures :
  1. Overall hospital length of stay [ Time Frame: 1 year ]
    Overall hospital length of stay


Secondary Outcome Measures :
  1. Hospitalization rate in ICU [ Time Frame: 1 year ]
    Rate of hospitalization in intensive care unit

  2. Readmissions within 30 days after hospital discharge [ Time Frame: 30 days ]
    Number of readmissions in our hospital in the 30 days after hospital discharge

  3. Transfer rate between units [ Time Frame: 1 year ]
    Transfer rate between units

  4. Cost of the OIPP implementation in our institution [ Time Frame: 1 year ]
    Cost of the OIPP implementation in our institution



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 2 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Chidren under 2 years hospitalized for bronchiolitis
Criteria

Inclusion criteria:

  • age < 2 years
  • hospitalization for bronchiolitis

Exclusion criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03663660


Locations
France
Uhmontpellier
Montpellier, France, 34295
Sponsors and Collaborators
University Hospital, Montpellier
Investigators
Principal Investigator: Pascal AMEDRO, MD, PhD University Hospital, Montpellier

Responsible Party: University Hospital, Montpellier
ClinicalTrials.gov Identifier: NCT03663660     History of Changes
Other Study ID Numbers: RECHMPL18_0174
First Posted: September 10, 2018    Key Record Dates
Last Update Posted: September 10, 2018
Last Verified: June 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: NC

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University Hospital, Montpellier:
Bronchiolitis
Health care
Organizational change
children
Epidemic
cost

Additional relevant MeSH terms:
Bronchiolitis
Bronchitis
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Infections